Magnetic resonance imaging of the breast: Opportunities to improve breast cancer management

被引：57
作者：
Hylton, N [1 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol, Magnet Resonance Sci Ctr, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期
关键词：
D O I：
10.1200/JCO.2005.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1678 / 1684
页数：7
相关论文
共 55 条
[1]   Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging [J].
Bedrosian, I ;
Mick, R ;
Orel, SG ;
Schnall, M ;
Reynolds, C ;
Spitz, FR ;
Callans, LS ;
Buzby, GP ;
Rosato, EF ;
Fraker, DL ;
Czerniecki, BJ .
CANCER, 2003, 98 (03) :468-473
[2]   False-negative MR imaging of malignant breast tumors [J].
Boetes, C ;
Strijk, SP ;
Holland, R ;
Barentsz, JO ;
VanderSluis, RF ;
Ruijs, JHJ .
EUROPEAN RADIOLOGY, 1997, 7 (08) :1231-1234
[3]   BREAST-TUMORS - COMPARATIVE ACCURACY OF MR-IMAGING RELATIVE TO MAMMOGRAPHY AND US FOR DEMONSTRATING EXTENT [J].
BOETES, C ;
MUS, RDM ;
HOLLAND, R ;
BARENTSZ, JO ;
STRIJK, SP ;
WOBBES, T ;
HENDRIKS, JHCL ;
RUYS, SHJ .
RADIOLOGY, 1995, 197 (03) :743-747
[4]   Medical progress - Ductal carcinoma in situ of the breast [J].
Burstein, HJ ;
Polyak, K ;
Wong, JS ;
Lester, SC ;
Kaelin, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1430-1441
[5]  
Chen Changhu, 2004, Clin Breast Cancer, V5, P72, DOI 10.3816/CBC.2004.n.012
[6]   Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging [J].
Esserman, L ;
Hylton, N ;
Yassa, L ;
Barclay, J ;
Frankel, S ;
Sickles, E .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :110-119
[7]   Applying the neoadjuvant paradigm to ductal carcinoma in situ [J].
Esserman, L ;
Sepucha, K ;
Ozanne, E ;
Hwang, ES .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (01) :28S-36S
[8]   Magnetic resonance imaging for primary breast cancer management: current role and new applications [J].
Esserman, L ;
Wolverton, D ;
Hylton, N .
ENDOCRINE-RELATED CANCER, 2002, 9 (02) :141-153
[9]   MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer [J].
Esserman, L ;
Kaplan, E ;
Partridge, S ;
Tripathy, D ;
Rugo, H ;
Park, J ;
Hwang, S ;
Kuerer, H ;
Sudilovsky, D ;
Lu, Y ;
Hylton, N .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (06) :549-559
[10]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685
123456